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1. Introduction 
The aim of the present chapter is to review the different ophthalmological signs and 
symptoms that can be observed in acute lymphoblastic leukemia and the importance of the 
examination of these patients by an ophthalmologist whenever an ocular affectation is 
suspected. 
Acute lymphoblastic leukemia is a malignant neoplasm caused by the proliferation of 
poorly differenciated precursors of the lymphoid cells, which are known as blast cells. Blast 
cells replace the normal elements of the bone marrow, decreasing the production of normal 
blood cells and, therefore, causing anemia, thrombocytopenia and neutropenia. They can 
also infiltrate other organs, such as liver, spleen, lymph nodes or, less frequently, central 
nervous system. (Florensa et al, 2006; Ribera & Ortega, 2003; Sharma et al, 2004) 
Acute lymphoblastic leukemia is the most common type of leukemia in children, although it 
is also seen in adult patients. If blood test results are abnormal or the doctor suspects 
leukemia despite normal cell counts, a bone marrow aspiration and biopsy are the next 
steps. Treatment is based on chemotherapy, radiotherapy and bone marrow transplantation. 
(Ribera & Ortega, 2003; Ortega, 2006; Ribera, 2006) 
The dominant clinical feature of these diseases is usually bone marrow failure caused by 
accumulation of blast cells although any organ can be infiltrated. Furthermore, signs and 
symptoms of acute lymphoblastic leukemia can be secondary to the toxicity of 
chemotherapy and/or radiotherapy, graft versus host reaction following bone marrow 
transplantation, or infections due to immunosuppression. They can include fever, weakness, 
fatigue, breathlessness, opportunistic infections, weight loss, anorexia, easy bruising and 
bleeding, thrombosis, edema of the lower limbs and the abdomen, swollen liver or spleen, 
lymphadenopathy, or bone pain. (Florensa et al, 2006; Ribera & Ortega, 2003; Ortega, 2006) 
Ophthalmological signs in patients suffering from leukemia were first described as 
“leukemic retinopathy” by Liebreich in 1863. (Campos-Campos et al, 2004; Guyer et al, 1989) 
Reports of patients with acute lymphoblastic leukemia presenting with visual symptoms as 
the initial sign of the disease are rare (Kim et al, 2010). However, ocular changes in acute 
lymphoblastic leukemia are common. They have been reported to occur in up to 90% of 
patients with this disease (Kincaid & Green, 1983; Mesa, 2003).  
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The improvement of the survival of patients suffering from acute lymphoblastic leukemia 
has increased the incidence of ocular manifestations they develop. Ocular involvement is 
associated with a higher frequency of bone marrow relapses and central nervous system 
compromise weeks or months later, which means a poor prognosis and a low survival rate. 
(Ohkoshi & Tsiaras, 1992)  Leukemic relapses are often diagnosed after ocular presentation. 
A lot of lesions are asymptomatic and the patient is diagnosed in a routine examination by 
an ophthalmologist. (Ribera & Ortega, 2003; Sharma et al, 2004; Ribera 2006) Therefore, it is 
important to consider an ophthalmic evaluation at the time of diagnosis of acute leukemia in 
adults and children. 
The treatment of the ocular manifestations is complicated, as the penetration of the 
chemotherapic drugs to the eye is quite difficult, even when they are injected intrathecally. 
Radiotherapy is also used for the treatment. (Ribera & Ortega, 2003; Ortega, 2006; Ribera, 
2006). 
All the structures of the eye and its adnexal structures can be affected by acute lymphoblastic 
leukemia. Ophthalmic involvement in acute lymphoblastic leukemia can be classified into two 
major categories: primary or direct leukemic infiltration of the ocular structures; and 
secondary or indirect involvement. These secondary changes may be the result of hematologic 
abnormalities such as anemia, thrombocytopenia, leucopenia, and hyperviscosity. Likewise, 
opportunistic infections due to immunosuppression -particularly viral, protozoal and fungal 
infections- and the leukemia treatment itself may secondarily involve the ocular system 
(Rosenthal, 1983; Wu et al, 2006), as well as graft-versus-host reaction or toxicity of the 
chemotherapy or radiotherapy. (Sharma et al, 2004; Rosenthal, 1983). 
2. Primary manifestations  
2.1 Orbit and eyelids  
All the structures of the orbit, including lacrimal glands, eyelids, soft tissues and 
extraocullar muscles, may become affected in the course of acute lymphoblastic leukemia. 
Orbital infiltration or a mass formation may cause exophtalmos and/or diplopia. Leukemic 
cells may infiltrate the soft tissues, extraocuar muscles or lacrimal glands. All kinds of 
leukemia can affect the orbit, but it is more common in acute lymphoblastic leukemias. 
(Cardone et al, 2006; Sharma et al, 2004) The symptoms are not different from those caused 
by other orbital masses, so the diagnosis is usually made after a biopsy of the mass and 
anatomopathological study. (Abdelouahed et al, 2005). 
When the eyelids are involved, they can suffer edema, inflammation, chemosis and pain. 
2.2 Conjunctiva  
Primary manifestations of conjunctiva involvement in acute lymphoblastic leukemia are 
caused by direct infiltration by blast cells. Hyperemia and edematization of the lower 
subpalpebral conjunctiva can be an unusual initial sign of acute lymphoblastic leukemia 
(Rosenthal, 1983). Infiltrates can also be seen, preferably around vessels (Fernández et al, 
1999) or in the form of  a conjunctival mass. (Cook & Bartley, 1997) 
2.3 Sclera  
Scleral infiltration is common during Acute lymphoblastic leukemia, around the episcleral 
vessels. It is usually asymptomatic and can be an autopsy finding (Sharma et al, 2004; 
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Burton et al, 2005). Sometimes, a slceral infiltration can simulate a scleritis. Recurrent 
episcleritis has been associated to adult T-cell leukemia. (Goto et al, 1993) 
2.4 Cornea  
Because cornea is an avascular structure, it is hardly ever affected by a direct leukemic 
infiltration. Occasionally there can be ring-shaped corneal ulcers, subepithelial limbal 
infiltrates and peripheral ulcers. (Taylor, 1997; Rosenthal, 1983; Eiferman et al, 1988). 
2.5 Anterior chamber and iridocorneal angle  
The space between cornea and lens may be affected in the form of anterior uveitis, 
pseudohypopyon or spontaneous hyphema. 
Most types of leukemias may show protean ocular manifestations ranging from leukemic 
retinopathy to involvement of the iris and anterior chamber (Decker & Burnstine, 1993).  
Clinically evident infiltration of the iris by leukemic cells is not common. It occurs associated 
with the involvement of choroid and ciliary body. It is characterized  by a change in iris 
color, and a pseudohypopyon, which is grey/yellow in color (Perry & Mallen, 1979). In 
acute lymphoblastic leukemia, hypopyon has been estimated at 2.5 to 18% of relapsed cases, 
depending on the stage of the disease (Decker & Burnstine, 1993; Yi et al, 2005; Wetzler & 
Lincoff, 2000; Ramsay & Lightman, 2001).  
 
 
Fig. 1. Sterile hypopion/pseudohypopion in a patient with acute lymphoblastic leukemia. 
Although leukemias have been identified as the cause of uveitis in only 5% of paediatric 
uveitis cases (Soylu et al, 1997), a hypopyon in a child would make us suspicious of a 
masquerade syndrome.  Anterior chamber involvement in cases of acute lymphoblastic 
leukemia relapse is typically bilateral (Yi et al, 2005). The mechanisms by which the cells 
migrate into the anterior chamber are not clear.  
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Fig. 2. Corneal precipitates in a case of uveitis secondary to acute lymphoblastic leukemia. 
On histopathological examination, the iris may show diffuse involvement, especially at the 
root and sphincter. An iris biopsy can give us the diagnosis of leukemia (Campos-Campos et 
al, 2004). The intraocular pressure can be high enough to cause signs and symptoms of acute 
glaucoma with normal depth of anterior chamber (Wolintz et al, 1971). The raised 
intraocular pressure is probably due to infiltration of the trabecular meshwork (Rowan & 
Sloan, 1976). 
Prompt anterior chamber paracentesis, and pathological studies should be done in such 
cases where history of leukemia is present even though other systemic investigations might 
indicate remission. Complete ocular examination including slit-lamp examination should be 
performed in all leukemic patients periodically. Early diagnosis is the aim to detect such 
extramedullary relapses so that timely referral and effective treatment can be initiated. 
(Campos-Campos et al, 2004) 
In children, spontaneous hyphema is also a presentation of leukemia (Perry & Mallen, 1979). 
Usually clinically apparent involvement of the iris and anterior segment occurs with acute 
lymphoblastic leukemia (Rowan & Sloan, 1976; Fonken & Ellis, 1966).  It may also occur less 
commonly with chronic lymphocytic leukemias (Martin, 1968) and myeloid leukemias 
(Perry & Mallen, 1979). 
Any ophthalmic manifestation in children with leukemia should be detected and treated 
early. Radiotherapy is warranted in infiltration of the anterior chamber. The presence of 
ocular or central nervous system involvement indicates poor prognosis in acute childhood 
leukemia. 
2.6 Retina  
The retina is involved in leukemia very commonly. It is estimated that up to 70% of all 
patients with leukemia show fundus changes during the course of their disease (Alemayehu 
et al, 1996).  Early manifestations are venous dilatation and tortuosity (Ballantyne & 
Michaelson, 1970). 
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Fig. 3. Vascular congestion and tortuosity in a leukemic retinopathy 
Other common retinal manifestations of acute lymphoblastic leukemia include retinal 
vascular sheathing, superficial retinal or intraretinal hemorrhages, and cotton wool spots, 
comprising what is called leukemic retinopathy (Rosenthal, 1983; Kincaid & Green, 1983; 
Park et al, 2000). Vascular occlusions have also been reported. 
 
 
Fig. 4. Central retinal vein occlusion in a patient with hyperviscosity. 
Retinal hemorrhages, usually in the posterior pole, may occur in all levels of the retina, but 
especially in the inner layers with focal destruction. They may be round or flame-shaped 
hemorrhages and often has a white component in the center. This white area consists of 
leukemic cells and debris, platelet-fibrin aggregates, or septic emboli (Abdallah et al, 2005). 
We may also see vitreous haemorrhages coming from retinal bleedings. 
Infiltrates and aggregates of leukemic cells are usually seen with surrounding hemorrhage 
(Kuwabara & Aiello, 1964). Large leukemic infiltrates can cause total retinal detachment 
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presenting as an isolated relapse (Primack et al, 1995). Smaller infiltrates tend to be 
perivascular. Subretinal infiltration in leukemia has been referred as subretinal hypopyon 
(Schworm et al, 1995). Cotton wool spots can be seen and are probably due to ischemia from 
anemia, hyperviscosity, or leukemic infiltration. 
 
 
Fig. 5. Cotton-wool spots in a case of acute lymphoblastic leukemia. 
Less frequent manifestations include microaneurysms which tend to be peripheral. The 
presence of microaneurysms is probably related to increased viscosity from elevated white 
blood cell count, and does not correlate with the hemoglobin level or platelet count (Jampol 
et al, 1975). 
The internal limiting membrane generally acts as an effective barrier to leukemic cell 
infiltration (Kuwabara & Aiello, 1964). However, leukemic cells occasionally invade the 
vitreous body, possibly emerging from the optic nerve head. So, a bilateral dense cellular 
infiltration has been reported (Reese & Guy, 1993; Swartz & Schumann, 1980; Zhioua et al, 
2001), resulting in a significant bilateral visual loss, and a vitrectomy may be necessary. 
Although less commonly, serous retinal detachment, has been reported in only a few cases 
of acute lymphoblastic leukemia world-wide (Kincaid & Green, 1983; Tang et al, 1988; 
Stewart et al, 1989; Dahreddine et al, 2004), especially as a presenting sign of the disease or 
the first sign of relapse (Yang & Yu, 2009; Kim et al 2010). 
Most of the reported cases of acute lymphoblastic leukemia with serous retinal detachment 
have involved younger patients (Reddy & Menon, 1998; Miyamoto et al, 2000; Malik et al, 
2005) and are reported to be shallow in the posterior pole (Stewart et al, 1989; Miyamoto et 
al, 2000). Serous retinal detachment may develop as a result of choroidal involvement by 
leukemic cells or due to incompetence of the outer blood-retinal barrier inducing retinal 
pigment epithelial changes (Stewart et al, 1989; Hine & Kingham, 1979). The differential 
diagnosis of serous retinal detachment includes Vogt-Koyanagi-Harada disease, central 
serous chorioretinopathy, uveal effusion syndrome, age-related macular degeneration, 
choroidal hemangioma and metastatic neoplasm. The choroid is the most frequently 
involved ocular tissue in leukemia. Leukemic cell infiltration or hematologic disturbances 
may cause partial occlusion of the choriocapillaries and delay of choroidal circulation. The 
fact that systemic chemotherapy induced a rapid remission of exudative retinal detachment, 
consistent with previous reports, suggests leukemic cell infiltration as the underlying 
pathology (Yang & Yu, 2009). With an appropriate and early treatment, that can include 
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systemic chemotherapy and radiotherapy, serous retinal detachment may resolve 
completely with good recovery of visual acuity (Kim et al, 2010). 
 
 
Fig. 6. Leukemic cells’ infiltration of the vitreous body. 
2.7 Choroid  
The choroid is the most commonly affected ocular tissue, but choroidal involvement is often 
not clinically apparent. Sometimes choroidal and orbital leukemic infiltrate mimic advanced 
retinoblastoma. There can be a diffuse or perivascular involvement. When it is affected, the 
overlying retina can show alterations such as photoreceptor damage, retinal pigment 
epithelium atrophy or serous retinal detachment, usually affecting the posterior pole. 
(McManaway & Neely, 1994; Campos-Campos et al, 2004) 
 
 
Fig. 7. Posterior pole serous detachment. 
Uveal effusion syndrome is caused mainly by disruption of the transscleral outflow of 
intraocular fluid. Cytological examination of the choroidal fluid may detect atypical 
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lymphoid cells (Kase et al, 2010; Campbell et al, 1990; Schmiegelow et al, 1988). Leukemic 
infiltration of the choroid may cause a serous detachment of the retina, which is often 
bilateral. The fluoroangiographic aspect is similar to what is observed in acute 
choriocapillaris occlusion. (De Laey & De Gersem, 1989) 
2.8 Optic nerve  
The optic nerve is usually involved in central nervous system leukemia. It can happen in up 
to 13 to 18% of leukemias. Central nervous system involvement is becoming more frequent 
as new, more effective treatments have allowed an improvement of the survival of patients 
suffering from acute lymphoblastic leukemia (Arruga, 2000; Nikaido et al, 1988). The 
symptoms of central nervous system leukemia depend on the rise of the intracranial 
pressure and the affectation of the cranial nerves. They can include lethargy, nausea, 
vomiting, seizures and ocular symptoms such as blurred vision, loss of visual acuity or 
diplopia, when the cranial nerves III, IV or VI are affected. Sometimes the affectation of the 
optic nerve is asymptomatic and only papilloedema can be found. (Ribera & Ortega, 2003; 
Lin et al, 2004; Sharma et al, 2004; Mayo et al, 2002) 
Papilloedema is the most frequent sign of optic nerve involvement. It can be due to direct 
infiltration of the nerve by leukemic cells, increased intraocular person, or swelling because 
of retrolaminar leukemic invasion. However, optic nerve can also be affected without the 
presence of papilloedema. (Joshi et al, 2009; Mateo et al, 2007; Bhatt et al 2008; Cleveland & 
Gelfand, 2009) 
 
Fig. 8. Massive papilloedema in a patient with acute lymphoblastic leukemia. 
The affectation of the optic nerve usually happens during the evolution of acute 
lymphoblastic leukemia, but it can also be the first sign of acute lymphoblastic leukemia or 
of extramedullary relapse after remission. (Mesa et all 2003) It always means a poor 
prognosis for the patient, especially if it happens when the patient is still receiving 
treatment, rather than after it. (Lo Curto et al, 1996; Bhatt et al, 2008; Schocket et al, 2003) 
The treatment of optic nerve involvement is quite difficult, as the optic nerve is relatively 
unaffected by systemic chemotherapy and serves as a sanctuary of acute lymphoblastic 
leukemia. It usually includes intratecal chemotherapy and radiotherapy. (Bandyopadhyay et 
al, 2010; Lo Curto et al, 1996) 
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3. Secondary manifestations  
3.1 Orbit and eyelids  
The structures of the orbit can show affectation after remission or secondary to 
chemotherapy, radiotherapy or graft versus host reaction. In immunocompromised patients, 
also opportunistic infections can happen. 
Lacrimal glands are affected frequently, either by direct infiltration by leukemic cells, graft 
versus host reaction or radiation, causing a tear dysfunction and dry eye. If severe, it can 
cause conjunctival and corneal problems such as queratoconjunctivitis sicca, corneal ulcers 
which can even lead to a corneal perforation and endophtalmitis. (Sharma et al, 2004; Im & 
Yoon, 2010). 
 
 
Fig. 9. Preseptal cellulitis in an immunocompromised patient. 
Infectious diseases such as preseptal cellulitis or acute dacryocystitis can be seen in 
immunocompromised patients. They should be treated with both antibiotics and 
chemotherapy, as soon as possible, to avoid further complications. (Im & Yoon, 2010; 
Wirostko et al, 1999) 
3.2 Conjunctiva 
Secondary manifestations to blood disorders are not common. Hyperviscosity can produce 
vascular anomalies in the conjunctiva, wich are more frequent in chronic leukemias. (Swartz 
& Jampol, 1975) 
The most common involvement of the conjunctiva comes from conjunctivitis secondary to 
dry eye after a graft versus host reaction. The bone marrow transplantation, in which 
allogeneic bone marrow obtained from a HLA-matched donor is used, can be a part of the 
treatment of acute lymphoblastic leukemia. The patients treated are predisposed to suffer a 
graft against host disease. The incidence of ocular affectation is variable according to the 
series, reaching to achieve 81.8% of cases, and it is considered a marker of poor prognosis. 
Keratoconjunctivitis sicca secondary to graft versus host reaction is difficult to manage. In 
the acute phase, there are four stages of severity: hyperemia, chemosis, pseudomembranous 
conjunctivitis with complete loss of conjunctival epithelium and finally, compromise of the 
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corneal epithelium. (Jabs et al, 1989; Sanders, 2002; Uchino et al, 2006) Its presence is related 
to vital prognosis with a mortality rate of 90% for stages 2 through 4 (Coskuncan 1994, 
Ohkoshi 1992). 
 
 
Fig. 10. Conjunctivitis sicca and corneal opacification in a patient with severe dry eye. 
Dysfunction of the meibomian glands is another common manifestation of chronic graft 
against host disease. It is estimated that up to half of patients receiving allogeneic bone 
marrow transplantation are going to develop a dry eye 6 months later. (Ogawa & Kuwana, 
1999) 
An almost pathognomonic sign of passage to chronicity is the appearance of fibrous lines in 
the tarsal conjunctiva (Mondéjar et al, 2001). The severe dryness and the progressive 
superficial keratinization evolve towards the formation of ectropion, cicatricial 
lagophthalmos and a palpebral lichenification. A major impact of this is the emergence of 
severe and recurrent corneal erosions and ulcerations, which can even evolve to the drilling 
of trophic or infectious origin. (Mittelviefhaus & Auw-Hadrich, 2003) 
 
 
Fig. 11. Ectropion in a severe dry eye patient. 
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Other secondary manifestations are those due to complications of the antileukemic 
treatment and opportunistic ocular infections. Direct toxicity of methotrexate is associated 
with the appearance of keratoconjunctivitis. The immunosuppression attached to marrow 
failure typical of the leukemia and the secondary to chemotherapy, favours infections by 
different microorganisms. (Fernández et al 1999; Cogan, 1977)  
3.3 Sclera  
Occasionally, immunocompromised patients suffer opportunistic infectious scleritis. 
3.4 Cornea  
Some drugs used for chemotherapy can produce corneal toxicity: citarabine produces 
corneal toxicity by interfering with epithelium´s synthesis of DNA. (Fernandez et al, 1999; 
Mondéjar et al, 2001) 
Keratoconjunctivitis sicca is the most common manifestation of graft versus host reaction. In 
the more severe cases, keratitis, corneal ulcers or corneal opacification are not uncommon. 
(Jabs et al, 1989; Uchino et al, 2006) The appearance of calcareous corneal degeneration in 
patients with severe dry eye in graft against host disease has also been described. In these 
cases the deposit of calcium salts occurs in all the layers of the cornea. (Lavid et al, 1995) 
However, sometimes there is a rapid development of extracellular deposits of calcium at 
subepithelial level, causing the appearance of acute calcium keratopathy that is located in 
the interpalpebral zone (Carreras & Muiños, 1996). Given the frequency and severity of 
these alterations of the ocular surface, it is important a close monitoring of all patients who 
received bone marrow transplant and especially those who develop a graft against host 
disease aimed at early detection. 
 
 
Fig. 12. Corneal opacification secondary to severe keratocojunctivitis sicca. 
In patients suffering from secondary immunosupression, infections by microorganisms such 
as herpes and fungi are favoured. Some secondary manifestations are keratitis, corneal 
thinning, ulcers and even corneal melting and perforation. (Fernández et al, 1999; Cogan, 
1977). 
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Fig. 13. Herpetic corneal ulcers. 
3.5 Anterior chamber and iridocorneal angle  
Extramedullary relapse of acute leukemias may masquerade as hypopyon uveitis (Ayliffe, 
1995). Primary relapse of acute leukemia in the anterior segment is not uncommon (Ayliffe, 
1995; Jancovic et al, 1995; MacLean et al, 1995; Soylu et al, 1997). 
It is possible an ischemia of the anterior segment secondary to anaemia or hyperviscosity. It 
might cause corneal edema, conjunctival chemosis, visual loss, anterior uveitis, increased 
intraocular pressure, cataracts and eye pain. (Sharma et al, 2004) 
Cataracts may also develop as a consequence of the use of stereoids, chemotherapy drugs or 
radiotherapy, or after ischemia caused by hyperviscosity or anaemia. (Elliott et al, 1985; 
Sharma et al 2004) 
 
 
Fig. 14. Subcapsular cataract caused by the use of corticosteroids. 
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3.6 Retina  
Patients with acute leukemia are susceptible to unusual and potentially life-threatening 
opportunistic infections that may involve the retina, especially during periods of 
neutropenia, which result both from the underlying disease as well as chemotherapy. These 
patients are susceptible to a wide variety of infections by viral (Cytomegalovirus, herpes 
virus), fungal (Candida, Aspergillus), protozoal, and bacterial organisms (Cogan, 1977). 
Cytomegalovirus infection is among the common viral infections in the 
immunocompromised hosts (Shibata et al, 1997). However, the prevalence of 
cytomegalovirus antigenemia and disease in patients with hematological malignancies who 
are not transplant recipients or HIV infected is largely unknown and is thought to be low 
(Taha et al, 2010). The virus invades the retina, causing necrosis, vascular sheathing, 
hemorrhage, and combined exudative and rhegmatogenous retinal detachment (Meredith et 
al, 1979). 
 
 
Fig. 15. Opportunistic infection by cytomegalovirus in a patient with neutropenia. 
 
 
Fig. 16. Vitritis caused by Candida infection. 
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Other viruses (herpes simplex, varicella zoster, and mumps) may also cause necrotizing 
retinitis in immunocompromised hosts (Cogan, 1977). Herpes zoster can also cause 
peripheral corneal ulcer, keratitis, and scleritis (Walton & Reed, 1999). Mumps virus has 
been reported to be a cause of granulomatous uveitis (Al-Rashid & Cress, 1977). Fungi are 
common causes of ocular infection in leukemias. Candida, especially Candida albicans, is 
among the common infections in this subset of patients; when it involves the retina, it 
typically appears as focal, deep white lesions that can be singular or multiple. It may extend 
into the vitreous and cause uveitis and retinitis with characteristic cotton balls in the 
vitreous (Cogan, 1977). The rate of developing chorioretinitis in patients with candidemia 
has reduced markedly since the 1990’s due to the early identification of candidemia in blood 
cultures coupled with a trend of early empiric antifungal therapy (Ninane et al, 1979). 
Aspergillus is also a common fungal infection in leukemic patients (Ellis & Little, 1973). 
3.7 Choroid  
Choroid secondary affectation is much less common than primary. Retinochoroidal infarction 
has been detected during the treatment of acute lymphoblastic leukemia. (Kato et al, 2006). 
3.8 Optic nerve  
Secondary optic nerve affectation include toxicity of chemotherapy, antibiotics or 
radiotherapy, ischemia after anaemia or hyperviscosity, and opportunistic infections in 
immunocompromised patients. (Joshi et al, 2009; Bhatt et al 2008; Cleveland & Gelfand, 2009). 
4. Conclusion  
Ophthalmological manifestations in patients suffering acute lymphoblastic leukemia are 
very common, partly thanks to the improvement of the survival because of the new and 
more efficient treatments, appearing in as much as 90% of the patients. They usually occur 
during the evolution of the illness, but they can be its first manifestation or the first sign of 
relapse after remission. (Kincaid & Green, 1983; Mesa, 2003) 
Ocular involvement can be caused by direct infiltration by leukemic cells or be secondary to 
anemia, thrombocytopenia, leucopenia, hyperviscosity and opportunistic infections in 
immunosuppressed patients. All the structures of the eye can be affected, as well as the 
orbit, the eyelids and the lacrimal glands. (Sharma et al, 2004) 
The treatment of the ocular manifestations is difficult, because the effect of chemotherapy in 
the eye is very limited. Radiotherapy is frequently used for the treatment. (Ribera & Ortega, 
2003; Ortega, 2006; Ribera, 2006) 
Every patient suffering acute lymphoblastic leukemia should get a complete 
ophthalmological exam regularly, to detect and treat eye problems in order to preserve 
vision and, even more important, in patients who are in remission, to diagnose relapses as 
soon as possible, because an early treatment can improve the patient’s vital prognosis. 
(Mateo et al, 2007) 
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